A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]
NYS Entity Status
NYS Filing Date
JUNE 04, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED PARTNERSHIP
2013 - AGRE EUROPE CO-INVEST ADVISORS, L.P.
AROUND THE WEB
- For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
By Ben Fidler - Wednesday Aug 9, 2017
- New York Today: New York Today: New Subway Clocks
By JONATHAN WOLFE - Monday Aug 7, 2017
Monday: Rolling out new subway clocks, the Corkscrew Theater Festival, and National Lighthouse Day.
- Conviction Overturned for ex-NY Assembly Speaker Sheldon Silver
Thursday Jul 13, 2017
A federal appeals court has overturned the corruption conviction of former New York Assembly Speaker Sheldon Silver.
- Woody Allen’s ‘Wonder Wheel’ set to close NY Film Festival
By Deadline - Tuesday Jul 25, 2017
The film will go into limited release December 1.
- AI-enhanced mobile trading app raises $25 million from Eastern Europe
By Vitaly Bulatov - Wednesday Aug 2, 2017
Two major investors from Russia and Belarus have just invested $25 million in Capital.com, a trading app that is similar to Robinhood in the US or Trading212 in Europe — but with a specific AI-powered function that provides users with tailored content based on behavioral analysis.This is the fourth deal under a $100 million investment program targeting AI startups, which was announced in early 2017 by Larnabel VC and VP Capital. The first investments went to Astro Digital, a California-based startup which develops open APIs for satellite imagery, Banuba, a startup with...Read More